Avanos Medical/$AVNS
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Avanos Medical
Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. Its operating and reportable segment provides medical device products to healthcare providers and patients. The company has now changed two franchises: has combined Chronic Care and Pain Management franchises into a single commercial organization focused on the Digestive Health and Pain Management and Recovery product categories that generate its revenue from its Chronic Care franchise and in North America.
Ticker
$AVNS
Sector
Primary listing
NYSE
Industry
Health Care Equipment and Supplies
Headquarters
Employees
2,227
Website
Avanos Medical Metrics
BasicAdvanced
$549M
-
-$8.37
1.14
-
Price and volume
Market cap
$549M
Beta
1.14
52-week high
$24.77
52-week low
$11.21
Average daily volume
457K
Financial strength
Current ratio
2.569
Quick ratio
1.471
Long term debt to equity
14.427
Total debt to equity
16.786
Interest coverage (TTM)
4.29%
Profitability
EBITDA (TTM)
91.7
Gross margin (TTM)
54.50%
Net profit margin (TTM)
-55.80%
Operating margin (TTM)
7.27%
Effective tax rate (TTM)
3.77%
Revenue per employee (TTM)
$310,000
Management effectiveness
Return on assets (TTM)
2.26%
Return on equity (TTM)
-36.78%
Valuation
Price to revenue (TTM)
0.792
Price to book
0.65
Price to tangible book (TTM)
1.99
Price to free cash flow (TTM)
4.791
Free cash flow yield (TTM)
20.87%
Free cash flow per share (TTM)
247.96%
Growth
Revenue change (TTM)
1.34%
Earnings per share change (TTM)
525.58%
3-year revenue growth (CAGR)
-1.59%
10-year revenue growth (CAGR)
-8.39%
3-year earnings per share growth (CAGR)
177.00%
10-year earnings per share growth (CAGR)
49.39%
What the Analysts think about Avanos Medical
Analyst ratings (Buy, Hold, Sell) for Avanos Medical stock.
Bulls say / Bears say
The implementation of the NOPAIN Act, effective January 1, 2025, provides separate payments for Avanos Medical's ON-Q and ambIT surgical pain pumps, potentially boosting revenue streams. (Monexa)
Avanos Medical reported a significant improvement in operating cash flow, increasing to $101 million in 2024 from $32 million in 2023, indicating enhanced financial health. (Panabee)
The company's Specialty Nutrition Systems segment experienced a 9% year-over-year growth in Q1 2025, driven by strong demand for NeoMed neonatal and pediatric feeding solutions. (Panabee)
Avanos Medical's gross margin contracted by 25 basis points to 54.6% in Q4 2024, indicating potential pricing pressures or increased costs. (Nasdaq)
The company lowered its adjusted diluted EPS guidance for 2025 to $0.75-$0.95, primarily due to the estimated impact of recently announced tariffs, suggesting potential profitability challenges. (Panabee)
Avanos Medical's stock price has decreased by 37.22% over the last 52 weeks, reflecting investor concerns and potential market challenges. (StockAnalysis)
Data summarised monthly by Lightyear AI. Last updated on 6 Jul 2025.
Avanos Medical Financial Performance
Revenues and expenses
Avanos Medical Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Avanos Medical stock?
Avanos Medical (AVNS) has a market cap of $549M as of July 25, 2025.
What is the P/E ratio for Avanos Medical stock?
The price to earnings (P/E) ratio for Avanos Medical (AVNS) stock is 0 as of July 25, 2025.
Does Avanos Medical stock pay dividends?
No, Avanos Medical (AVNS) stock does not pay dividends to its shareholders as of July 25, 2025.
When is the next Avanos Medical dividend payment date?
Avanos Medical (AVNS) stock does not pay dividends to its shareholders.
What is the beta indicator for Avanos Medical?
Avanos Medical (AVNS) has a beta rating of 1.14. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.